PD-L1-targeted PET imaging for non-invasive assessment of immunotherapy response in lung cancer
Journal for ImmunoTherapy of Cancer · 2026-04 · 14 (4) · e013837
DOI: 10.1136/jitc-2025-013837 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 01.04.2026. Verfasst von Yang Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: PET Center, Department of Nuclear Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical Universi…. Hauptthemen laut MEDLINE: Lung Neoplasms, Positron-Emission Tomography, Gallium Isotopes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Guangdong Provincial People’s Hospital, National Key Research and Development Program of China.
Abstract (Originalsprache)
Background
Immune checkpoint inhibitors have improved outcomes for several malignancies; however, there remains a lack of accurate, non-invasive methods to assess tumor PD-L1 expression levels and guide immunotherapy. This study aimed to evaluate the role of PD-L1-targeted positron emission tomography (PET) imaging in predicting immunotherapy response and prognosis in lung cancer.
Methods
Four healthy volunteers and 22 treatment-naïve lung cancer patients were prospectively enrolled and underwent [ 68 Ga]Ga-PDL1p PET imaging. All patients additionally completed paired baseline [ 18 F]fluorodeoxyglucose ([ 18 F]FDG) PET scans. Of the 22 patients, 17 received ≥3 cycles of immunotherapy combined with chemotherapy and underwent follow-up [ 18 F]FDG PET or CT examinations. The correlations of baseline [ 68 Ga]Ga-PDL1p and [ 18 F]FDG uptake with tumor PD-L1 expression were evaluated. Furthermore, the associations of tumor [ 68 Ga]Ga-PDL1p uptake, [ 18 F]FDG uptake, and PD-L1 expression with immunotherapy response were analyzed, along with their predictive values for immunotherapy efficacy and outcomes.
Results
Lesions with high PD-L1 expression exhibited significantly higher [ 68 Ga]Ga-PDL1p uptake than those with low expression (p=0.007), whereas [ 18 F]FDG uptake showed no significant difference (p=0.499). At baseline, [ 68 Ga]Ga-PDL1p uptake was significantly higher in responders than in non-responders (p=0.008), with an area under the receiver operating characteristic curve of 0.886. In contrast, neither [ 18 F]FDG uptake nor PD-L1 expression levels differed significantly between the two groups. Disease progression occurred in 23.5% of patients (4/17) by the final follow-up. Patients with higher [ 68 Ga]Ga-PDL1p uptake or higher [ 18 F]FDG uptake demonstrated significantly longer progression-free survival (PFS) than those with lower uptake (p=0.033 and p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- PET Center, Department of Nuclear Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
- Department of Pulmonary Surgery, Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
- Department of Pathology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
- Nanfang PET Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- Department of Pulmonary Surgery, Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China jianglei6814@gdph.org.cn yu…
- PET Center, Department of Nuclear Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China jianglei6814@gdph.org.cn yuanhui@gdph.org.cn jian…
Förderung
- Guangdong Provincial People’s Hospital
- National Key Research and Development Program of China
Zitieren
APA
Chen, Y., Liu, X., Hu, Y., Li, A., Zeng, B., Wang, P., Tang, G., Jiang, B., Yuan, H., & Jiang, L. (2026). PD-L1-targeted PET imaging for non-invasive assessment of immunotherapy response in lung cancer. Journal for ImmunoTherapy of Cancer, 14(4), e013837. https://doi.org/10.1136/jitc-2025-013837
Vancouver
Chen Y, Liu X, Hu Y, Li A, Zeng B, Wang P, et al. PD-L1-targeted PET imaging for non-invasive assessment of immunotherapy response in lung cancer. Journal for ImmunoTherapy of Cancer. 2026;14(4):e013837. doi:10.1136/jitc-2025-013837
BibTeX
@article{Chen2026,
author = {Chen, Yang and Liu, Xiufeng and Hu, Yinting and Li, Ao and Zeng, Baozhen and Wang, Peng and Tang, Ganghua and Jiang, Benyuan and Yuan, Hui and Jiang, Lei},
title = {PD-L1-targeted PET imaging for non-invasive assessment of immunotherapy response in lung cancer},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2026},
volume = {14},
number = {4},
pages = {e013837},
doi = {10.1136/jitc-2025-013837}
}
EUVIMED